Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Truly Refractory Hodgkin Lymphoma Patients Is Highly Effective and Responses Are Mediated By NK Cells

Blood (2023) 142 (Supplement 1): 2218.

https://doi.org/10.1182/blood-2023-189574

Published: 2023

Journal Articles

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated with Expansion and Maturation of NK Cells

Blood (2022) 140 (Supplement 1): 11549–11551.

https://doi.org/10.1182/blood-2022-169136

Published: 2022

Journal Articles

Hematologic Recovery after Allogeneic Transplantation: Risk Factors and Its IMPACT on Transplant Related Mortality

Sabrina Giammarco, Carmen Di Grazia, Anna Maria Raiola, Stefania Bregante, Riccardo Varaldo, Francesca Gualandi, Simona Sica, Patrizia Chiusolo, Federica Sora, Luca Laurenti, Elisabetta Metafuni, Andrea Bacigalupo, Emanuele Angelucci

Blood (2021) 138 (Supplement 1): 2867.

https://doi.org/10.1182/blood-2021-147903

Published: 2021

Journal Articles

Total Marrow Irradiation for Second Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia

Alida Dominietto, MD, Stefano Vagge, MD, Susanta Hui, PhD, Carmen Di Grazia, MD, Teresa Lamparelli, MD, Stefania Bregante, MD, Anna Maria Raiola, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Renzo Corvò, MD, Emanuele Angelucci, MD

Blood (2020) 136 (Supplement 1): 32.

https://doi.org/10.1182/blood-2020-140669

Published: 2020

Journal Articles

The Effect of Prolonged Graft Versus Myelofibrosis May Influence the Prognosis of Patients with Myelofibrosis Relapsing after Allogenic Hematopoietic Stem Cell Transplantation: A Single Center Experience

Daniele Avenoso, Stefania Bregante, Anna Maria Raiola, MD, Riccardo Varaldo, Francesca Gualandi, Alida Dominietto, MD, Giannoni Livia, Carlo Marani, Carmen Di Grazia, MD, Teresa Lamparelli, Maria Teresa van Lint, Emanuele Angelucci

Blood (2017) 130 (Supplement 1): 5539.

https://doi.org/10.1182/blood.V130.Suppl_1.5539.5539

Published: 2017

Journal Articles

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

Andrea Bacigalupo, MD, H. Joachim Deeg, MD, Dolores Caballero, MD PhD, Francesca Gualandi, MD, Anna Maria Raiola, MD, Riccardo Varaldo, MD, Carmen Di Grazia, MD, Lucia López Corral, PhD MD, Maria Teresa van Lint, MD

Blood (2016) 128 (22): 671.

https://doi.org/10.1182/blood.V128.22.671.671

Published: 2016

Journal Articles

PRE-Transplant Positron Emission Tomography (PET) Predicts Outcomes of Patients with Hodgkin disease Undergoing Reduced Intensity Conditioning Haploidentical Transplant

Carlo Marani, MD, Silvia Morbelli, MD, Anna Maria Raiola, MD, Alida Dominietto, MD, Giulia Ferrarazzo, MD, Sandro Nati, MD, Marina Congiu, MD, Stefania Bregante, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3489.

https://doi.org/10.1182/blood.V128.22.3489.3489

Published: 2016

Journal Articles

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Anna Maria Raiola, MD, Sara Aquino, MD, Germana Beltrami, MD, Stefania Bregante, MD, Fabio Cruciani, MD, Carmen Di Grazia, MD, Alida Dominietto, MD, Anna Ghiso, MD, Francesca Gualandi, MD, Adalberto Ibatici, MD, Teresa Lamparelli, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Riccardo Varaldo, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2016) 128 (22): 3173.

https://doi.org/10.1182/blood.V128.22.3173.3173

Published: 2016

Journal Articles

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Carmen Di Grazia, MD, Simona Geroldi, Raffaella Grasso, PhD, Maurizio Miglino, PhD, Nicoletta Colombo, PhD, Elisabetta Tedone, Silvia Luchetti, Teresa Lamparelli, Francesca Gualandi, MD, Adalberto Ibatici, MD, Stefania Bregante, Maria Teresa van Lint, Anna Maria Raiola, Alida Dominietto, MD, Riccardo Varaldo, Federica Galaverna, Anna Ghiso, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 1866.

https://doi.org/10.1182/blood.V126.23.1866.1866

Published: 2015

Journal Articles

Natural Killer (NK) Alloreactivity Seems Not to Play a Role in Preventing Leukemia Relapse in Unmanipulated Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide

Federica Galaverna, MD, Fabio Guolo, MD, Daniela Pende, MD, Alida Dominietto, MD, Raffaella Meazza, PhD, Michela Falco, PhD, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Anna Ghiso, MD, Riccardo Varaldo, MD, Francesca Gualandi, MD, Carlo Marani, MD, Maria Teresa van Lint, MD, Roberto Massimo Lemoli, MD, Marco Gobbi, MD, Paola Minetto, MD, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 2033.

https://doi.org/10.1182/blood.V126.23.2033.2033

Published: 2015

Journal Articles

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

Stefania Bregante, Alida Dominietto, MD, Anna Ghiso, Anna Maria Raiola, Francesca Gualandi, MD, Riccardo Varaldo, Carmen Di Grazia, MD, Teresa Lamparelli, Silvia Luchetti, Simona Geroldi, Lucia Casarino, Sarah Pozzi, Elisabetta Tedone, Maria Teresa van Lint, MD, Federica Galaverna, Gianni Barosi, Andrea Bacigalupo, MD

Blood (2015) 126 (23): 4336.

https://doi.org/10.1182/blood.V126.23.4336.4336

Published: 2015

Journal Articles

Post-Transplant Cyclophosphamide Following a Myeloablative Conditioning For Hematologic Malignancies Receiving An Unmanipulated Haploidentical Bone Marrow Transplant

Anna Maria Raiola, Anna Ghiso, Alida Dominietto, Carmen Di Grazia, Francesca Gualandi, Riccardo Varaldo, Federica Galaverna, Maria Teresa Van Lint, Teresa Lamparelli, Stefania Bregante, Maurizio Miglino, PHD, Filippo Ballerini, PHD, Andrea Bacigalupo, MD

Blood (2013) 122 (21): 2103.

https://doi.org/10.1182/blood.V122.21.2103.2103

Published: 2013

Journal Articles

CD34+ Selected Cells For The Treatment Of Poor Graft Function Following Allogeneic Stem Cell Transplantation

Alessandra Stasia, MD, Anna Ghiso, Anna Maria Raiola, Federica Galaverna, Riccardo Varaldo, Francesca Gualandi, Alida Dominietto, Sarah Pozzi, Silvia Luchetti, Enrico Maria Pogliani, MD, Andrea Bacigalupo, MD

Blood (2013) 122 (21): 3306.

https://doi.org/10.1182/blood.V122.21.3306.3306

Published: 2013

Journal Articles

How We Treat Chronic Myeloid Leukemia Patients During Daily Practice? Case Studies From The Real Life Experience Of Two Genoa Centers Of Hematology

Laura Mitscheunig, Micaela Bergamaschi, MD, Raffalla Grosso, Maurizio Miglino, PHD, Marino Clavio, MD, Filippo Ballerini, PHD, Letizia Canepa, MD, Riccardo Varaldo, Roberto Lemoli, Marco Gobbi, MD, Ivana Pierri, MD

Blood (2013) 122 (21): 5192.

https://doi.org/10.1182/blood.V122.21.5192.5192

Published: 2013

Journal Articles

Unmanipulated Haploidentical Bone Marrow Transplantation and Post-Transplant Cyclophosphamide for Hematologic Malignanices Following A Myeloablative Conditioning.

Andrea P Bacigalupo, Anna Maria Raiola, Alida Dominietto, Maria Teresa Van Lint, MD, Francesca Gualandi, Teresa Lamparelli, Stefania Bregante, Anna Ghiso, Carmen Di Grazia, Riccardo Varaldo

Blood (2012) 120 (21): 3034.

https://doi.org/10.1182/blood.V120.21.3034.3034

Published: 2012

Journal Articles

Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis

Anna Ghiso, Annamaria Raiola, Francesca Gualandi, Alida Dominietto, Riccardo Varaldo, Maria Teresa van Lint, Stefania Bregante, Carmen Di Grazia, Teresa Lamparelli, Silvia Luchetti, Simona Geroldi, Elisabetta Tedone, Andrea P Bacigalupo

Blood (2012) 120 (21): 1950.

https://doi.org/10.1182/blood.V120.21.1950.1950

Published: 2012

Journal Articles

Rapid Immune Reconstitution Following Unmanipulated Haploidentical BMT with Post-Transplant High Dose Cyclophosphamide

Alida Dominietto, Anna Maria Raiola, Barbara Bruno, Maria Teresa van Lint, Francesco Frassoni, MD, Carmen Di Grazia, Francesca Gualandi, Stefania Bregante, Riccardo Varaldo, Anna Ghiso, Andrea Bacigalupo

Blood (2011) 118 (21): 3050.

https://doi.org/10.1182/blood.V118.21.3050.3050

Published: 2011

Journal Articles

DONOR LYMPHOCYTE INFUSIONS (DLI): Risk Factors for Non Relapse Mortality (NRM) In 287 Patients Receiving DLI

Andrea Bacigalupo, MD, Anna Maria Raiola, Alida Dominietto, Carmen Di Grazia, Francesca Gualandi, Teresa Lamparelli, Stefania Bregante, Francesco Frassoni, MD, Riccardo Varaldo, Silvana Annunziata, Maria Teresa van Lint

Blood (2010) 116 (21): 2333.

https://doi.org/10.1182/blood.V116.21.2333.2333

Published: 2010

Journal Articles

The Intra-Bone Route of Administration of Cord blood cells extends the Possibility of Transplantation to the Majority of Patients with Malignant Hematopoietic Diseases.

Francesco Frassoni, MD, Marina Podestà, BiolSci, Simona Pollichieni, Ph.D., Francesca Gualandi, MD, GianLuca Ubezio, MD, Lucia Garbarino, MD, Teresa Lamparelli, MD, Riccardo Varaldo, MD, Gianmario Sambuceti, MD, Myriam Labopin, MD, Andrea Bacigalupo, MD, Nicoletta Sacchi, Ph.D

Blood (2009) 114 (22): 3376.

https://doi.org/10.1182/blood.V114.22.3376.3376

Published: 2009

Journal Articles

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Anna Garuti, PhD, Adalberto Ibatici, MD, Gabriella Cirmena, PhD, Maurizio Miglino, MD, Riccardo Varaldo, MD, Colombo Nicoletta, PhD, Roberta Grasso, PhD, Sarah Pozzi, PhD, Marina Podesta, PhD, Marco Gobbi, MD, Mario Sessarego, MD, Franco Patrone, MD, Francesco Frassoni, MD

Blood (2005) 106 (11): 3282.

https://doi.org/10.1182/blood.V106.11.3282.3282

Published: 2005

NARROW

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Truly Refractory Hodgkin Lymphoma Patients Is Highly Effective and Responses Are Mediated By NK Cells

Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated with Expansion and Maturation of NK Cells

Hematologic Recovery after Allogeneic Transplantation: Risk Factors and Its IMPACT on Transplant Related Mortality

Total Marrow Irradiation for Second Allogeneic Haematopoietic Stem Cell Transplantation in Patients with Advanced Acute Leukemia

The Effect of Prolonged Graft Versus Myelofibrosis May Influence the Prognosis of Patients with Myelofibrosis Relapsing after Allogenic Hematopoietic Stem Cell Transplantation: A Single Center Experience

Treatment of Patients with Steroid Refractory Acute Graft Vs Host Disease (SR-GvHD): A Matched Paired Analysis of Anti-CD26 (Begelomab) Compared to Other Treatment

PRE-Transplant Positron Emission Tomography (PET) Predicts Outcomes of Patients with Hodgkin disease Undergoing Reduced Intensity Conditioning Haploidentical Transplant

Haploidentical Allogeneic Hemopoietic Stem Cell Transplant for High Risk Myelodysplastic Syndrome

Allogeneic Transplanst for ACUTE Myeloid Leukemia: Cut Off Levels of WT1 Expression in 207 Patients and Pre-Emptive Therapy of Relapse

Natural Killer (NK) Alloreactivity Seems Not to Play a Role in Preventing Leukemia Relapse in Unmanipulated Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide

Allogeneic STEM CELL Transplants for Patients with Myelofibrosis: Changes in the Transplant Platform and Improved the Outcome

Post-Transplant Cyclophosphamide Following a Myeloablative Conditioning For Hematologic Malignancies Receiving An Unmanipulated Haploidentical Bone Marrow Transplant

CD34+ Selected Cells For The Treatment Of Poor Graft Function Following Allogeneic Stem Cell Transplantation

How We Treat Chronic Myeloid Leukemia Patients During Daily Practice? Case Studies From The Real Life Experience Of Two Genoa Centers Of Hematology

Unmanipulated Haploidentical Bone Marrow Transplantation and Post-Transplant Cyclophosphamide for Hematologic Malignanices Following A Myeloablative Conditioning.

Donor Lymphocyte Infusions (DLI) Following Haplo Bone Marrow Transplantation (hBMT) with High-Dose of Cyclophosphamide Post-Transplant As Gvhd Prophylaxis

Rapid Immune Reconstitution Following Unmanipulated Haploidentical BMT with Post-Transplant High Dose Cyclophosphamide

DONOR LYMPHOCYTE INFUSIONS (DLI): Risk Factors for Non Relapse Mortality (NRM) In 287 Patients Receiving DLI

The Intra-Bone Route of Administration of Cord blood cells extends the Possibility of Transplantation to the Majority of Patients with Malignant Hematopoietic Diseases.

The Persistence of p190 BCR-ABL Transcripts Is Associated with Lower Probability of Molecular Response to Imatinib in Early and Late Chronic Phase CML Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only